Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRQR | CRDF | ZNTL | ||
| Company | Proqr Therapeutics | Cardiff Oncology Inc | Zentalis Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.59 | 4.42 | 2.90 | ||
| High | 2.70 | 4.67 | 3.10 | ||
| Low | 2.47 | 4.20 | 2.89 | ||
| Last | 2.63 | 4.26 | 3.00 | ||
| Change | +0.04 | -0.23 | +0.07 | ||
| % Change | +1.54% | -5.12% | +2.39% | ||
| Volume | 718,700 | 2,099,000 | 1,854,000 | ||
| 20-Day Average Volume | 625,010 | 4,268,240 | 1,051,455 | ||
| Previous Close | 2.59 | 4.49 | 2.93 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.28 | 3.23 | 3.35 | ||
| 20-Day Raw Stochastic | 21.41% | 59.18% | 17.01% | ||
| 20-Day Relative Strength | 40.40% | 59.70% | 43.70% | ||
| Weighted Alpha | -40.77 | +7.88 | -72.59 | ||
| Today's Opinion | 24% Buy | 72% Buy | 80% Sell | ||
| Previous Opinion | 24% Buy | 56% Buy | 80% Sell | ||
| Last Month's Opinion | 96% Buy | 24% Sell | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.07% since 12/13/24 | +8.67% since 12/13/24 | -2.91% since 12/13/24 | ||
| Low | 2.27 on 12/16/24 | 3.76 on 12/16/24 | 2.80 on 12/19/24 | ||
| High | 2.95 on 12/18/24 | 5.64 on 12/17/24 | 3.25 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | -28.34% since 11/20/24 | +68.38% since 11/20/24 | -4.15% since 11/20/24 | ||
| Low | 2.27 on 12/16/24 | 2.26 on 12/06/24 | 2.80 on 12/19/24 | ||
| High | 3.97 on 11/29/24 | 5.64 on 12/17/24 | 4.00 on 12/09/24 | ||
| 3-Month | |||||
| %Chg | +52.02% since 09/20/24 | +58.96% since 09/20/24 | -28.91% since 09/20/24 | ||
| Low | 1.65 on 09/24/24 | 2.26 on 12/06/24 | 2.66 on 10/31/24 | ||
| High | 4.62 on 10/17/24 | 5.64 on 12/17/24 | 4.44 on 11/13/24 | ||
| 6-Month | |||||
| %Chg | +53.80% since 06/20/24 | +74.59% since 06/20/24 | -42.86% since 06/20/24 | ||
| Low | 1.61 on 07/03/24 | 2.01 on 08/05/24 | 2.66 on 10/31/24 | ||
| High | 4.62 on 10/17/24 | 5.64 on 12/17/24 | 5.47 on 06/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 214,818 | 217,831 | 213,795 | ||
| Shares Outstanding, K | 81,680 | 51,134 | 71,265 | ||
| Annual Sales | 7,050,000 | 490,000 | 0 | ||
| Annual Net Income | -30,430,000 | -41,440,000 | -292,190,000 | ||
| Last Quarter Sales | 4,230,000 | 170,000 | 0 | ||
| Last Quarter Net Income | -8,920,000 | -11,860,000 | -88,280,000 | ||
| 60-Month Beta | 0.24 | 1.89 | 1.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 11/07/24 | -0.25 on 11/07/24 | -0.56 on 11/12/24 | ||
| Latest Earnings Date | 11/12/24 | 11/07/24 | 11/18/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||